908 Devices, Inc. 65443P102 06/10/2026 Approval of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 300000 0 FOR 300000 FOR Beam Therapeutics, Inc. 07373V105 06/03/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 4540132 0 FOR 4540132 FOR Lyell Immnopharma, Inc. 55083R203 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 3247162 0 FOR 3247162 FOR Gossamer, Inc. 38341P102 06/04/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 8055916 0 FOR 8055916 FOR Neumora, Inc. 640979100 05/27/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 31932138 0 FOR 31932138 FOR Scholar Rock, Inc. 80706P103 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 2345711 0 FOR 2345711 FOR 10X Genomics, Inc. 88025U109 06/04/2026 To approve, on a non-binding , advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 217834 0 FOR 217834 FOR Vir Biotechnology, Inc. 92764N102 05/26/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 12916663 0 FOR 12916663 FOR Q32 Bio Inc. 746964105 06/12/2026 Approval of, on a non-binding , advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 320482 0 FOR 320482 FOR